RSV

Precision Clinical Research's Dr. Jason Haffizulla sat down with WLPG Channel 10 HealthCast to discuss the clinical trial we are conducting (part of a large scale clinical trial) into a vaccine for respiratory syncytial virus, or RSV, for adults over the age of 60.